MetLife Investment Management’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-26,780
Closed -$278K 2876
2022
Q2
$278K Buy
26,780
+3,546
+15% +$26.4K ﹤0.01% 2073
2022
Q1
$205K Buy
23,234
+5,144
+28% +$39K ﹤0.01% 2343
2021
Q4
$125K Buy
18,090
+6,895
+62% +$101K ﹤0.01% 2323
2021
Q3
$139K Sell
11,195
-6,742
-38% -$97.2K ﹤0.01% 2287
2021
Q2
$327K Hold
17,937
﹤0.01% 1833
2021
Q1
$374K Sell
17,937
-2,947
-14% -$62.1K ﹤0.01% 1689
2020
Q4
$373K Hold
20,884
﹤0.01% 1628
2020
Q3
$237K Hold
20,884
﹤0.01% 1763
2020
Q2
$285K Hold
20,884
﹤0.01% 1683
2020
Q1
$271K Hold
20,884
﹤0.01% 1531
2019
Q4
$421K Hold
20,884
﹤0.01% 1553
2019
Q3
$538K Hold
20,884
0.01% 1381
2019
Q2
$509K Buy
20,884
+3,322
+19% +$72.6K 0.01% 1469
2019
Q1
$350K Hold
17,562
﹤0.01% 1662
2018
Q4
$290K Hold
17,562
﹤0.01% 1700
2018
Q3
$313K Hold
17,562
﹤0.01% 1831
2018
Q2
$518K Hold
17,562
0.01% 1390
2018
Q1
$631K Hold
17,562
0.01% 1239
2017
Q4
$558K Buy
+17,562
New +$551K 0.01% 1338

Other funds holding RDUS

MetLife Investment Management's RDUS Position: Q3 2022 in Review

MetLife Investment Management sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 26,780 shares — an estimated $278K sold.

MetLife Investment Management first reported a position in RDUS in Q4 2017 and held it in 19 quarters. The position peaked at $631K in Q1 2018. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • MetLife Investment Management reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • MetLife Investment Management sold 26,780 Radius Health, Inc. shares in Q3 2022, an estimated $278K.
  • MetLife Investment Management first reported a position in Radius Health, Inc. in Q4 2017 and held it in 19 quarters.
  • MetLife Investment Management's Radius Health, Inc. position peaked at $631K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.